Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance.
Journal: Future oncology (London, England)
Published: June 16, 2026
Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy.
Journal: JCO clinical cancer informatics
Published: June 18, 2025
A Novel Artificial Intelligence-powered Tool for Precise Risk Stratification of Prostate Cancer Progression in Patients with Clinical Intermediate Risk.
Journal: European urology
Published: April 24, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
Journal: The Journal of clinical investigation
Published: October 24, 2023
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 05, 2023
Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool.
Journal: JCO clinical cancer informatics
Published: March 24, 2023
A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.
Journal: JCO clinical cancer informatics
Published: February 22, 2022
Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities.
Journal: The Prostate
Published: September 30, 2020
A Festschrift in Honor of Edward M. Messing, MD, FACS.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: November 17, 2018
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.
Journal: Clinical genitourinary cancer
Published: August 24, 2017
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 02, 2017
Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 01, 2016
Last Updated: 09/26/2026